Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients

Clinical trial NCT00299221 · COMPLETED

Trial details

NCT number: NCT00299221
Sponsor: Newark Beth Israel Medical Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Immunosuppression

Start date: 2004-04-01
Primary completion: 2009-06-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.